512 related articles for article (PubMed ID: 26456352)
1. Purinergic receptors in embryonic and adult neurogenesis.
Oliveira Á; Illes P; Ulrich H
Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
[TBL] [Abstract][Full Text] [Related]
2. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signaling in retinal degeneration and regeneration.
Reichenbach A; Bringmann A
Neuropharmacology; 2016 May; 104():194-211. PubMed ID: 25998275
[TBL] [Abstract][Full Text] [Related]
4. P2 receptor interaction and signalling cascades in neuroprotection.
Miras-Portugal MT; Queipo MJ; Gil-Redondo JC; Ortega F; Gómez-Villafuertes R; Gualix J; Delicado EG; Pérez-Sen R
Brain Res Bull; 2019 Sep; 151():74-83. PubMed ID: 30593879
[TBL] [Abstract][Full Text] [Related]
5. Nucleotides in neuroregeneration and neuroprotection.
Miras-Portugal MT; Gomez-Villafuertes R; Gualix J; Diaz-Hernandez JI; Artalejo AR; Ortega F; Delicado EG; Perez-Sen R
Neuropharmacology; 2016 May; 104():243-54. PubMed ID: 26359530
[TBL] [Abstract][Full Text] [Related]
6. ATPergic signalling during seizures and epilepsy.
Engel T; Alves M; Sheedy C; Henshall DC
Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.
Resende RR; Britto LR; Ulrich H
Int J Dev Neurosci; 2008 Nov; 26(7):763-77. PubMed ID: 18675894
[TBL] [Abstract][Full Text] [Related]
8. Purinergic receptors in neurogenic processes.
Ribeiro DE; Glaser T; Oliveira-Giacomelli Á; Ulrich H
Brain Res Bull; 2019 Sep; 151():3-11. PubMed ID: 30593881
[TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation.
del Puerto A; Díaz-Hernández JI; Tapia M; Gomez-Villafuertes R; Benitez MJ; Zhang J; Miras-Portugal MT; Wandosell F; Díaz-Hernández M; Garrido JJ
J Cell Sci; 2012 Jan; 125(Pt 1):176-88. PubMed ID: 22250198
[TBL] [Abstract][Full Text] [Related]
10. Purinergic neurone-glia signalling in cognitive-related pathologies.
Illes P; Verkhratsky A
Neuropharmacology; 2016 May; 104():62-75. PubMed ID: 26256423
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
12. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and structure of P2Y receptors.
von Kügelgen I; Hoffmann K
Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyogenesis of embryonic stem cells upon purinergic receptor activation by ADP and ATP.
Mazrouei S; Sharifpanah F; Bekhite MM; Figulla HR; Sauer H; Wartenberg M
Purinergic Signal; 2015 Dec; 11(4):491-506. PubMed ID: 26395809
[TBL] [Abstract][Full Text] [Related]
15. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
[TBL] [Abstract][Full Text] [Related]
16. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
17. Purinergic P2X, P2Y and adenosine receptors differentially modulate hippocampal gamma oscillations.
Schulz SB; Klaft ZJ; Rösler AR; Heinemann U; Gerevich Z
Neuropharmacology; 2012 Feb; 62(2):914-24. PubMed ID: 22001427
[TBL] [Abstract][Full Text] [Related]
18. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide signaling in astrogliosis.
Franke H; Illes P
Neurosci Lett; 2014 Apr; 565():14-22. PubMed ID: 24103370
[TBL] [Abstract][Full Text] [Related]
20. The selective antagonism of P2X7 and P2Y1 receptors prevents synaptic failure and affects cell proliferation induced by oxygen and glucose deprivation in rat dentate gyrus.
Maraula G; Lana D; Coppi E; Gentile F; Mello T; Melani A; Galli A; Giovannini MG; Pedata F; Pugliese AM
PLoS One; 2014; 9(12):e115273. PubMed ID: 25526634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
